International Stem Cell EBITDA Margin 2010-2023 | ISCO

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for International Stem Cell (ISCO) over the last 10 years. The current EBITDA margin for International Stem Cell as of December 31, 2023 is .
International Stem Cell EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $0.01B 0 0.00%
2023-09-30 $0.01B 0 0.00%
2023-06-30 $0.01B 0 0.00%
2023-03-31 $0.01B 0 0.00%
2022-12-31 $0.01B 0 0.00%
2022-09-30 $0.01B 0 0.00%
2022-06-30 $0.01B $-0.00B -12.50%
2022-03-31 $0.01B $-0.00B -12.50%
2021-12-31 $0.01B $-0.00B -25.00%
2021-09-30 $0.01B $-0.00B -42.86%
2021-06-30 $0.01B $-0.00B -50.00%
2021-03-31 $0.01B $-0.00B -66.67%
2020-12-31 $0.01B $-0.00B -50.00%
2020-09-30 $0.01B $-0.00B -50.00%
2020-06-30 $0.01B $-0.00B -44.44%
2020-03-31 $0.01B $-0.00B -44.44%
2019-12-31 $0.01B $-0.01B -55.56%
2019-09-30 $0.01B $-0.00B -50.00%
2019-06-30 $0.01B $-0.00B -44.44%
2019-03-31 $0.01B $-0.00B -30.00%
2018-12-31 $0.01B $-0.00B -27.27%
2018-09-30 $0.01B $-0.00B -36.36%
2018-06-30 $0.01B $-0.00B -40.00%
2018-03-31 $0.01B $-0.01B -55.56%
2017-12-31 $0.01B $-0.01B -62.50%
2017-09-30 $0.01B $-0.00B -50.00%
2017-06-30 $0.01B $-0.00B -50.00%
2017-03-31 $0.01B $-0.00B -50.00%
2016-12-31 $0.01B $-0.00B -50.00%
2016-09-30 $0.01B $-0.00B -50.00%
2016-06-30 $0.01B $-0.00B -50.00%
2016-03-31 $0.01B $-0.00B -50.00%
2015-12-31 $0.01B $-0.01B -62.50%
2015-09-30 $0.01B $-0.01B -75.00%
2015-06-30 $0.01B $-0.01B -87.50%
2015-03-31 $0.01B $-0.01B -100.00%
2014-12-31 $0.01B $-0.01B -100.00%
2014-09-30 $0.01B $-0.01B -100.00%
2014-06-30 $0.01B $-0.01B -100.00%
2014-03-31 $0.01B $-0.01B -114.29%
2013-12-31 $0.01B $-0.01B -133.33%
2013-09-30 $0.01B $-0.01B -160.00%
2013-06-30 $0.00B $-0.01B -200.00%
2013-03-31 $0.00B $-0.01B -200.00%
2012-12-31 $0.00B $-0.01B -225.00%
2012-09-30 $0.00B $-0.01B -250.00%
2012-06-30 $0.00B $-0.01B -275.00%
2012-03-31 $0.00B $-0.01B -300.00%
2011-12-31 $0.01B $-0.01B -220.00%
2011-09-30 $0.01B $-0.01B -200.00%
2011-06-30 $0.00B $-0.01B -250.00%
2011-03-31 $0.00B $-0.01B -333.33%
2010-12-31 $0.00B $-0.01B -1000.00%
2010-09-30 $0.00B $-0.01B inf%
2010-06-30 $0.00B $-0.01B inf%
2010-03-31 $0.00B $-0.01B inf%
2009-12-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.008B
International Stem Cell Corporation is a biotechnology company currently focused on developing therapeutic and research products. In the area of therapeutic product development, ISCO's objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease and retinal disease through cell transplant therapy. In furtherance of this objective, ISCO has developed pluripotent human stem cells from unfertilized human eggs, and techniques to cause those stem cells to be differentiated into the specific cell types required for transplant. It has developed manufacturing protocols to produce the cells minimizing contamination with animal by-products, a characteristic likely to be important in meeting U.S. Food and Drug Administration requirements. ISCO also provides the specialized cells and growth media needed for therapeutic cell transplantation research to academic and commercial researchers in related fields.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $149.322B 14.94
Vertex Pharmaceuticals (VRTX) United States $103.425B 29.77
Regeneron Pharmaceuticals (REGN) United States $102.914B 25.27
GSK (GSK) United Kingdom $89.840B 10.73
Bristol Myers Squibb (BMY) United States $88.584B 41.62
CSL (CSLLY) Australia $88.000B 0.00
Gilead Sciences (GILD) United States $81.341B 16.21
Moderna (MRNA) United States $48.086B 0.00
Biogen (BIIB) United States $31.086B 14.23
Argenex SE (ARGX) Netherlands $23.381B 0.00
BioNTech SE (BNTX) Germany $21.928B 22.39
Illumina (ILMN) United States $19.746B 140.90
Alnylam Pharmaceuticals (ALNY) United States $18.931B 0.00
Genmab (GMAB) Denmark $18.329B 21.49
BioMarin Pharmaceutical (BMRN) United States $15.912B 62.07
BeiGene (BGNE) Cayman Islands $15.495B 0.00
Sarepta Therapeutics (SRPT) United States $12.348B 1088.58
Incyte (INCY) United States $11.921B 18.43
Bio-Techne Corp (TECH) United States $11.884B 45.00
Exact Sciences (EXAS) United States $11.130B 0.00
QIAGEN (QGEN) Netherlands $9.740B 20.81
Repligen (RGEN) United States $9.293B 121.39
Roivant Sciences (ROIV) United Kingdom $9.058B 0.00
Legend Biotech (LEGN) United States $8.355B 0.00
Viking Therapeutics (VKTX) United States $8.354B 0.00
Ascendis Pharma (ASND) Denmark $8.215B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Vaxcyte (PCVX) United States $6.998B 0.00
Intra-Cellular Therapies (ITCI) United States $6.809B 0.00
Cytokinetics (CYTK) United States $6.728B 0.00
Blueprint Medicines (BPMC) United States $6.548B 0.00
Exelixis (EXEL) United States $6.443B 34.56
ImmunityBio (IBRX) United States $6.073B 0.00
Apellis Pharmaceuticals (APLS) United States $5.760B 0.00
Halozyme Therapeutics (HALO) United States $5.059B 15.62
CRISPR Therapeutics AG (CRSP) Switzerland $4.675B 0.00
Nuvalent (NUVL) United States $4.644B 0.00
Zealand Pharma (ZLDPF) Denmark $4.599B 0.00
Krystal Biotech (KRYS) United States $4.569B 0.00
Immunovant (IMVT) United States $4.182B 0.00
Alkermes (ALKS) Ireland $4.038B 15.80
Insmed (INSM) United States $3.812B 0.00
Iovance Biotherapeutics (IOVA) United States $3.604B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.590B 0.00
Axsome Therapeutics (AXSM) United States $3.524B 0.00
Biohaven (BHVN) United States $3.522B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.408B 0.00
Fortrea Holdings (FTRE) United States $3.276B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.245B 0.00
Janux Therapeutics (JANX) United States $3.237B 0.00
SpringWorks Therapeutics (SWTX) United States $3.199B 0.00
IDEAYA Biosciences (IDYA) United States $3.102B 0.00
Amicus Therapeutics (FOLD) United States $3.089B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.962B 0.00
Arcellx (ACLX) United States $2.840B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.822B 0.00
Certara (CERT) United States $2.821B 60.72
Merus (MRUS) Netherlands $2.788B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.720B 0.00
MorphoSys AG (MOR) Germany $2.692B 0.00
CG Oncology (CGON) United States $2.632B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.499B 0.00
Avidity Biosciences (RNA) United States $2.446B 0.00
Denali Therapeutics (DNLI) United States $2.396B 0.00
Vera Therapeutics (VERA) United States $2.369B 0.00
Vericel (VCEL) United States $2.316B 0.00
Celldex Therapeutics (CLDX) United States $2.284B 0.00
Guardant Health (GH) United States $2.261B 0.00
Intellia Therapeutics (NTLA) United States $2.244B 0.00
Apogee Therapeutics (APGE) United States $2.241B 0.00
Kymera Therapeutics (KYMR) United States $2.227B 0.00
Arvinas (ARVN) United States $2.215B 0.00
Geron (GERN) United States $2.160B 0.00
Sana Biotechnology (SANA) United States $2.156B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.087B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.066B 0.00
Keros Therapeutics (KROS) United States $2.059B 0.00
Galapagos (GLPG) Belgium $1.941B 0.00
NeoGenomics (NEO) United States $1.880B 0.00
Beam Therapeutics (BEAM) United States $1.870B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.857B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.853B 0.00
Twist Bioscience (TWST) United States $1.851B 0.00
Structure Therapeutics (GPCR) United States $1.817B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.800B 13.72
Edgewise Therapeutics (EWTX) United States $1.796B 0.00
Inhibrx (INBX) United States $1.778B 0.00
Myriad Genetics (MYGN) United States $1.739B 0.00
Bavarian Nordic (BVNRY) Denmark $1.689B 5.55
Zai Lab (ZLAB) China $1.646B 0.00
Kura Oncology (KURA) United States $1.569B 0.00
ADMA Biologics Inc (ADMA) United States $1.538B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.535B 0.00
Dynavax Technologies (DVAX) United States $1.534B 0.00
Protagonist Therapeutics (PTGX) United States $1.498B 0.00
Neumora Therapeutics (NMRA) United States $1.470B 0.00
Morphic Holding (MORF) United States $1.438B 0.00
ANI Pharmaceuticals (ANIP) United States $1.415B 17.39
Arcus Biosciences (RCUS) United States $1.410B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.369B 0.00
Akero Therapeutics (AKRO) United States $1.363B 0.00
Spyre Therapeutics (SYRE) United States $1.311B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.308B 0.00
Ligand Pharmaceuticals (LGND) United States $1.280B 15.86
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.273B 0.00
Vir Biotechnology (VIR) United States $1.235B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.206B 0.00
Gyre Therapeutics (GYRE) United States $1.204B 0.00
Scholar Rock Holding (SRRK) United States $1.204B 0.00
Belite Bio (BLTE) United States $1.198B 0.00
Cullinan Therapeutics (CGEM) United States $1.188B 0.00
MannKind (MNKD) United States $1.186B 0.00
Prothena (PRTA) Ireland $1.184B 0.00
AbCellera Biologics (ABCL) Canada $1.132B 0.00
MiMedx (MDXG) United States $1.107B 46.88
Autolus Therapeutics (AUTL) United Kingdom $1.093B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.039B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.994B 0.00
Liquidia Technologies (LQDA) United States $0.991B 0.00
Tyra Biosciences (TYRA) United States $0.973B 0.00
Abivax SA (ABVX) France $0.939B 0.00
Viridian Therapeutics (VRDN) United States $0.931B 0.00
Praxis Precision Medicines (PRAX) United States $0.927B 0.00
Immatics (IMTX) Germany $0.922B 0.00
Immunome (IMNM) United States $0.897B 0.00
89BIO (ETNB) United States $0.844B 0.00
Mesoblast (MESO) Australia $0.832B 0.00
ALX Oncology Holdings (ALXO) United States $0.831B 0.00
CARGO Therapeutics (CRGX) United States $0.825B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.822B 0.00
REGENXBIO (RGNX) United States $0.816B 0.00
Cytek Biosciences (CTKB) United States $0.814B 0.00
Tango Therapeutics (TNGX) United States $0.810B 0.00
Pliant Therapeutics (PLRX) United States $0.799B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.789B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.757B 0.00
PureTech Health (PRTC) United States $0.755B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.742B 0.00
AnaptysBio (ANAB) United States $0.720B 0.00
WAVE Life Sciences (WVE) Singapore $0.719B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.714B 0.00
Nuvation Bio (NUVB) United States $0.713B 0.00
Dianthus Therapeutics (DNTH) United States $0.705B 0.00
Disc Medicine (IRON) United States $0.700B 0.00
HilleVax (HLVX) United States $0.697B 0.00
Cogent Biosciences (COGT) United States $0.697B 0.00
Prime Medicine (PRME) United States $0.673B 0.00
Pharming Group (PHAR) Netherlands $0.671B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.669B 0.00
EnGene Holdings (ENGN) United States $0.668B 0.00
Novavax (NVAX) United States $0.661B 0.00
Mineralys Therapeutics (MLYS) United States $0.650B 0.00
Kyverna Therapeutics (KYTX) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Oric Pharmaceuticals (ORIC) United States $0.642B 0.00
Zymeworks (ZYME) United States $0.635B 0.00
Castle Biosciences (CSTL) United States $0.627B 0.00
Nurix Therapeutics (NRIX) United States $0.626B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
CureVac (CVAC) Germany $0.620B 0.00
Stoke Therapeutics (STOK) United States $0.609B 0.00
Aerovate Therapeutics (AVTE) United States $0.596B 0.00
Cabaletta Bio (CABA) United States $0.590B 0.00
GH Research (GHRS) Ireland $0.582B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.571B 0.00
Olema Pharmaceuticals (OLMA) United States $0.563B 0.00
Absci (ABSI) United States $0.563B 0.00
ArriVent BioPharma (AVBP) United States $0.563B 0.00
Northwest Biotherapeutics (NWBO) United States $0.562B 0.00
IGM Biosciences (IGMS) United States $0.554B 0.00
Celcuity (CELC) United States $0.538B 0.00
Shattuck Labs (STTK) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Humacyte (HUMA) United States $0.524B 0.00
Oculis Holding AG (OCS) Switzerland $0.523B 0.00
Avid Bioservices (CDMO) United States $0.521B 0.00
Applied Therapeutics (APLT) United States $0.518B 0.00
Alector (ALEC) United States $0.515B 0.00
Astria Therapeutics (ATXS) United States $0.513B 0.00
Allogene Therapeutics (ALLO) United States $0.507B 0.00
Arbutus Biopharma (ABUS) United States $0.481B 0.00
Adlai Nortye (ANL) Cayman Islands $0.480B 0.00
Fulcrum Therapeutics (FULC) United States $0.475B 0.00
Third Harmonic Bio (THRD) United States $0.472B 0.00
PepGen (PEPG) United States $0.469B 0.00
Travere Therapeutics (TVTX) United States $0.469B 0.00
Fate Therapeutics (FATE) United States $0.467B 0.00
Voyager Therapeutics (VYGR) United States $0.464B 2.76
Editas Medicine (EDIT) United States $0.462B 0.00
Entrada Therapeutics (TRDA) United States $0.457B 0.00
Neurogene (NGNE) United States $0.455B 0.00
C4 Therapeutics (CCCC) United States $0.442B 0.00
Adaptive Biotechnologies (ADPT) United States $0.432B 0.00
Biomea Fusion (BMEA) United States $0.430B 0.00
Annexon (ANNX) United States $0.425B 0.00
ACELYRIN, INC (SLRN) United States $0.420B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.419B 0.00
TScan Therapeutics (TCRX) United States $0.414B 0.00
ITeos Therapeutics (ITOS) United States $0.413B 0.00
Anika Therapeutics (ANIK) United States $0.409B 0.00
Mersana Therapeutics (MRSN) United States $0.408B 0.00
Replimune (REPL) United States $0.403B 0.00
MaxCyte (MXCT) United States $0.400B 0.00
Revance Therapeutics (RVNC) United States $0.393B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.392B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.389B 0.00
Solid Biosciences (SLDB) United States $0.387B 0.00
Alto Neuroscience (ANRO) United States $0.387B 0.00
Aura Biosciences (AURA) United States $0.385B 0.00
Amarin (AMRN) Ireland $0.377B 0.00
Erasca (ERAS) United States $0.373B 0.00
Nkarta (NKTX) United States $0.372B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.365B 0.00
Tenaya Therapeutics (TNYA) United States $0.363B 0.00
Jasper Therapeutics (JSPR) United States $0.361B 0.00
Precigen (PGEN) United States $0.348B 0.00
Ventyx Biosciences (VTYX) United States $0.346B 0.00
Terns Pharmaceuticals (TERN) United States $0.342B 0.00
Ocugen (OCGN) United States $0.340B 0.00
Nautilus Biotechnology (NAUT) United States $0.334B 0.00
Urogen Pharma (URGN) United States $0.334B 0.00
Caribou Biosciences (CRBU) United States $0.329B 0.00
Atea Pharmaceuticals (AVIR) United States $0.323B 0.00
MeiraGTx Holdings (MGTX) United States $0.321B 0.00
Kamada (KMDA) Israel $0.320B 24.17
Rani Therapeutics Holdings (RANI) United States $0.320B 0.00
Anavex Life Sciences (AVXL) United States $0.309B 0.00
CytomX Therapeutics (CTMX) United States $0.307B 0.00
XOMA (XOMA) United States $0.296B 0.00
CorMedix Inc (CRMD) United States $0.294B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.294B 0.00
Inozyme Pharma (INZY) United States $0.288B 0.00
ChromaDex (CDXC) United States $0.284B 0.00
Rapt Therapeutics (RAPT) United States $0.283B 0.00
Invivyd (IVVD) United States $0.283B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.282B 0.00
Inovio Pharmaceuticals (INO) United States $0.281B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.272B 93.60
Contineum Therapeutics (CTNM) United States $0.272B 0.00
Poseida Therapeutics (PSTX) United States $0.270B 0.00
Werewolf Therapeutics (HOWL) United States $0.264B 0.00
Verastem (VSTM) United States $0.262B 0.00
Agenus (AGEN) United States $0.254B 0.00
2seventy Bio (TSVT) United States $0.253B 0.00
Candel Therapeutics (CADL) United States $0.247B 0.00
Coherus BioSciences (CHRS) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.246B 0.00
XBiotech (XBIT) United States $0.244B 0.00
23andMe Holding (ME) United States $0.244B 0.00
AC Immune (ACIU) Switzerland $0.241B 0.00
Puma Biotechnology (PBYI) United States $0.239B 15.03
Prima BioMed (IMMP) Australia $0.237B 0.00
Codexis (CDXS) United States $0.236B 0.00
G1 Therapeutics (GTHX) United States $0.232B 0.00
Compass Therapeutics (CMPX) United States $0.227B 0.00
UniQure (QURE) Netherlands $0.224B 0.00
FibroBiologics (FBLG) United States $0.219B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.218B 0.00
Ovid Therapeutics (OVID) United States $0.217B 0.00
Renovaro (RENB) United States $0.214B 0.00
Trevi Therapeutics (TRVI) United States $0.212B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.209B 0.00
Elevation Oncology (ELEV) United States $0.209B 0.00
Adverum Biotechnologies (ADVM) United States $0.208B 0.00
Design Therapeutics (DSGN) United States $0.206B 0.00
INmune Bio (INMB) United States $0.203B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.199B 0.00
Akoya Biosciences (AKYA) United States $0.197B 0.00
Innate Pharma S.A (IPHA) France $0.196B 0.00
Kodiak Sciences (KOD) United States $0.194B 0.00
Opthea (OPT) Australia $0.194B 0.00
Lifecore Biomedical (LFCR) United States $0.193B 0.00
Zura Bio (ZURA) United States $0.188B 0.00
Compugen (CGEN) Israel $0.187B 0.00
Alimera Sciences (ALIM) United States $0.182B 0.00
X4 Pharmaceuticals (XFOR) United States $0.181B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
Gossamer Bio (GOSS) United States $0.174B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
Emergent Biosolutions (EBS) United States $0.173B 0.00
Adocia (ADOCY) France $0.169B 0.00
ScPharmaceuticals (SCPH) United States $0.168B 0.00
Inventiva S.A (IVA) France $0.168B 0.00
Seres Therapeutics (MCRB) United States $0.168B 0.00
Cellectis S.A (CLLS) France $0.166B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.162B 0.00
Skye Bioscience (SKYE) United States $0.160B 0.00
Omega Therapeutics (OMGA) United States $0.152B 0.00
BioAtla (BCAB) United States $0.152B 0.00
CervoMed (CRVO) United States $0.149B 0.00
BioStem Technologies (BSEM) $0.146B 0.00
I-Mab (IMAB) China $0.142B 0.00
Repare Therapeutics (RPTX) Canada $0.142B 0.00
Sagimet Biosciences (SGMT) United States $0.142B 0.00
Scilex Holding (SCLX) United States $0.141B 0.00
Seer (SEER) United States $0.140B 0.00
Syros Pharmaceuticals (SYRS) United States $0.139B 0.00
Molecular Partners AG (MOLN) Switzerland $0.137B 0.00
PDS Biotechnology (PDSB) United States $0.137B 0.00
Cartesian Therapeutics (RNAC) United States $0.132B 0.00
DBV Technologies S.A (DBVT) France $0.129B 0.00
Coya Therapeutics (COYA) United States $0.128B 0.00
Nuvectis Pharma (NVCT) United States $0.124B 0.00
Vor Biopharma (VOR) $0.120B 0.00
Immunic (IMUX) United States $0.120B 0.00
Rezolute (RZLT) United States $0.119B 0.00
VistaGen Therapeutics (VTGN) United States $0.119B 0.00
Adicet Bio (ACET) United States $0.116B 0.00
TELA Bio (TELA) United States $0.114B 0.00
Abeona Therapeutics (ABEO) United States $0.111B 0.00
Oncobiologics (OTLK) United States $0.111B 0.00
ATyr Pharma (LIFE) United States $0.109B 0.00
Sangamo Therapeutics (SGMO) United States $0.108B 0.00
Adagene (ADAG) China $0.106B 0.00
BioHarvest Sciences (CNVCF) Canada $0.105B 0.00
Vigil Neuroscience (VIGL) United States $0.103B 0.00
IO Biotech (IOBT) Denmark $0.101B 0.00
DiaMedica Therapeutics (DMAC) United States $0.100B 0.00
Bluebird Bio (BLUE) United States $0.099B 0.00
Clearside Biomedical (CLSD) United States $0.099B 0.00
Allakos (ALLK) United States $0.097B 0.00
Curis (CRIS) United States $0.097B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
BioXcel Therapeutics (BTAI) United States $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Genelux (GNLX) United States $0.093B 0.00
Gritstone Bio (GRTS) United States $0.093B 0.00
Elicio Therapeutics (ELTX) United States $0.092B 0.00
Cue Biopharma (CUE) United States $0.091B 0.00
HOOKIPA Pharma (HOOK) United States $0.091B 0.00
Oncolytics Biotech (ONCY) Canada $0.088B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.087B 0.00
Spero Therapeutics (SPRO) United States $0.087B 3.22
Connect Biopharma Holdings (CNTB) United States $0.085B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.085B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.084B 0.00
BeyondSpring (BYSI) United States $0.084B 0.00
Q32 Bio (QTTB) United States $0.084B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.083B 0.00
Passage Bio (PASG) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.081B 0.00
Leap Therapeutics (LPTX) United States $0.081B 0.00
Affimed (AFMD) Germany $0.081B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.080B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.080B 0.00
Cognition Therapeutics (CGTX) United States $0.079B 0.00
Alpha Teknova (TKNO) United States $0.079B 0.00
Atara Biotherapeutics (ATRA) United States $0.078B 0.00
Galena Biopharma (SLS) United States $0.078B 0.00
AN2 Therapeutics (ANTX) United States $0.076B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.076B 0.00
Athira Pharma (ATHA) United States $0.075B 0.00
Precision BioSciences (DTIL) United States $0.075B 0.00
Instil Bio (TIL) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.071B 0.00
Landos Biopharma (LABP) United States $0.069B 0.00
Rallybio (RLYB) United States $0.069B 0.00
YS Biopharma (YS) China $0.069B 0.00
Elutia (ELUT) United States $0.068B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Aileron Therapeutics (ALRN) United States $0.064B 0.00
CalciMedica (CALC) United States $0.064B 0.00
Aligos Therapeutics (ALGS) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Bionano Genomics (BNGO) United States $0.063B 0.00
Kezar Life Sciences (KZR) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Celularity (CELU) United States $0.060B 0.00
Turnstone Biologics (TSBX) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Annovis Bio (ANVS) United States $0.060B 0.00
LENZ Therapeutics (LENZ) United States $0.060B 0.00
Lantern Pharma (LTRN) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.058B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.057B 0.00
Clene (CLNN) United States $0.056B 0.00
AVROBIO (AVRO) United States $0.055B 0.00
Equillium (EQ) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.053B 0.00
HCW Biologics (HCWB) United States $0.050B 0.00
Aadi Bioscience (AADI) United States $0.050B 0.00
Prenetics Global (PRE) Cayman Islands $0.049B 0.00
Ocean Biomedical (OCEA) United States $0.049B 0.00
Eyenovia (EYEN) United States $0.048B 0.00
Ocuphire Pharma (OCUP) United States $0.047B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Immuneering (IMRX) United States $0.046B 0.00
OKYO Pharma (OKYO) $0.045B 0.00
Beyond Air (XAIR) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Cara Therapeutics (CARA) United States $0.042B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
NextCure (NXTC) United States $0.042B 0.00
Quince Therapeutics (QNCX) United States $0.041B 0.00
Sensei Biotherapeutics (SNSE) United States $0.041B 0.00
Carmell (CTCX) United States $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Promis Neurosciences (PMN) Canada $0.038B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Apollomics (APLM) United States $0.037B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
IN8bio (INAB) United States $0.033B 0.00
Theratechnologies (THTX) Canada $0.032B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
Spruce Biosciences (SPRB) United States $0.031B 0.00
NKGen Biotech (NKGN) United States $0.030B 0.00
Aprea Therapeutics (APRE) United States $0.030B 0.00
Pluri (PLUR) Israel $0.029B 0.00
Evogene (EVGN) Israel $0.029B 0.00
UNITY Biotechnology (UBX) United States $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.025B 0.00
Lumos Pharma (LUMO) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Benitec Biopharma (BNTC) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Synlogic (SYBX) United States $0.022B 0.00
RenovoRx (RNXT) United States $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Semper Paratus Acquisition (TVGN) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Purple Biotech (PPBT) Israel $0.014B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
Vaxxinity (VAXX) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Psyence Biomedical (PBM) United States $0.011B 0.00
Telesis Bio (TBIO) United States $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.008B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Cingulate (CING) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
ThermoGenesis Holdings (THMO) United States $0.006B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Longeveron (LGVN) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
NexImmune (NEXI) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00